SEC Form 4 · accession 0001190251-17-000004

ICU MEDICAL INC/DE · ICUI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Joseph R Saucedo

Director

Period of report

Oct 9, 2017

Accepted (ET)

Oct 10, 2017 · 12:44 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000883984

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Oct 9, 2017	X	1,500	$32.40	A	4,591	D
Common Stock	Oct 9, 2017	X	1,500	$33.52	A	6,091	D
Common Stock	Oct 9, 2017	X	1,500	$37.00	A	7,591	D
Common Stock	Oct 9, 2017	X	1,500	$43.12	A	9,091	D
Common Stock	Oct 9, 2017	X	1,500	$36.60	A	10,591	D
Common Stock	Oct 9, 2017	X	1,500	$39.38	A	12,091	D
Common Stock^F1,F2	Oct 9, 2017	S	600	$189.0135	D	11,491	D
Common Stock^F1,F3	Oct 9, 2017	S	2,100	$189.4824	D	9,391	D
Common Stock^F1,F4	Oct 9, 2017	S	300	$190.6667	D	9,091	D
Common Stock^F1,F5	Oct 9, 2017	S	1,200	$189.00	D	7,891	D
Common Stock^F1,F6	Oct 9, 2017	S	4,600	$189.487	D	3,291	D
Common Stock^F1,F7	Oct 9, 2017	S	200	$190.85	D	3,091	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Non-Qualified Stock Option (right to buy)	$32.40	Oct 9, 2017	X	1,500	D	Feb 3, 2011	Feb 3, 2020	Common Stock	1,500	D
Non-Qualified Stock Option (right to buy)	$33.52	Oct 9, 2017	X	1,500	D	Apr 21, 2011	Apr 21, 2020	Common Stock	1,500	D
Non-Qualified Stock Option (right to buy)	$36.60	Oct 9, 2017	X	1,500	D	Oct 20, 2011	Oct 20, 2020	Common Stock	1,500	D
Non-Qualified Stock Option (right to buy)	$37.00	Oct 9, 2017	X	1,500	D	Jul 21, 2011	Jul 21, 2020	Common Stock	1,500	D
Non-Qualified Stock Option (right to buy)	$39.38	Oct 9, 2017	X	1,500	D	Oct 19, 2012	Oct 19, 2021	Common Stock	1,500	D
Non-Qualified Stock Option (right to buy)	$43.12	Oct 9, 2017	X	1,500	D	Feb 2, 2012	Feb 2, 2021	Common Stock	1,500	D

Explanation of responses

F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 7, 2017.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.25 to $189.20, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.25 to $190.05, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.40 to $191.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.20 to $189.15, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.20 to $190.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F7The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.70 to $191.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.